Table 1. Prostacyclin Receptor Agonist Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Prostacyclin Receptor Agonist Market Restraints

Table 3. Prostacyclin Receptor Agonist Market Trends

Table 4. Prostacyclin Receptor Agonist Industry Policy

Table 5. Global Prostacyclin Receptor Agonist Revenue by Company, 2018-2023, US$ million

Table 6. Global Prostacyclin Receptor Agonist Revenue Market Share by Company, 2018-2023

Table 7. Global Prostacyclin Receptor Agonist Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Prostacyclin Receptor Agonist Sales Volume Market Share by Company, 2018-2023

Table 9. Global Prostacyclin Receptor Agonist Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Prostacyclin Receptor Agonist Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Prostacyclin Receptor Agonist Mergers & Acquisitions, Expansion Plans

Table 12. Global Prostacyclin Receptor Agonist Manufacturers Product Type

Table 13. China Prostacyclin Receptor Agonist Revenue by Company, 2018-2023, US$ million

Table 14. China Prostacyclin Receptor Agonist Revenue Market Share by Company, 2018-2023

Table 15. China Prostacyclin Receptor Agonist Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Prostacyclin Receptor Agonist Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Prostacyclin Receptor Agonist Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Prostacyclin Receptor Agonist Import & Export Trends

Table 19. Main Sources of China Prostacyclin Receptor Agonist Import

Table 20. Export Destination of China Prostacyclin Receptor Agonist

Table 21. Global Headquarters and Manufacturing Base of Prostacyclin Receptor Agonist Manufacturers

Table 22. Global Major Manufacturers, Prostacyclin Receptor Agonist Capacity Expansion and Future Plans

Table 23. Global Prostacyclin Receptor Agonist Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Prostacyclin Receptor Agonist Production by Region, 2018-2023, (K Units)

Table 25. Global Prostacyclin Receptor Agonist Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Prostacyclin Receptor Agonist Upstream (Raw Materials)

Table 27. Global Prostacyclin Receptor Agonist Typical Customers

Table 28. Prostacyclin Receptor Agonist Typical Distributors

Table 29. By Type, Global Prostacyclin Receptor Agonist Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Prostacyclin Receptor Agonist Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Prostacyclin Receptor Agonist Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Prostacyclin Receptor Agonist Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Prostacyclin Receptor Agonist Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Prostacyclin Receptor Agonist Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Prostacyclin Receptor Agonist Revenue Market Share, 2018-2029

Table 37. By Country, Global Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Prostacyclin Receptor Agonist Sales Volume Market Share, 2018-2029

Table 39. United Therapeutics Corporation Company Information, Head Office, Market Area and Industry Position

Table 40. United Therapeutics Corporation Prostacyclin Receptor Agonist Models, Specifications and Application

Table 41. United Therapeutics Corporation Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. United Therapeutics Corporation Company Profile and Main Business

Table 43. United Therapeutics Corporation Recent Developments

Table 44. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 45. Pfizer Prostacyclin Receptor Agonist Models, Specifications and Application

Table 46. Pfizer Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Pfizer Company Profile and Main Business

Table 48. Pfizer Recent Developments

Table 49. Insmed Incorporated Company Information, Head Office, Market Area and Industry Position

Table 50. Insmed Incorporated Prostacyclin Receptor Agonist Models, Specifications and Application

Table 51. Insmed Incorporated Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Insmed Incorporated Company Profile and Main Business

Table 53. Insmed Incorporated Recent Developments

Table 54. Gilead Sciences Company Information, Head Office, Market Area and Industry Position

Table 55. Gilead Sciences Prostacyclin Receptor Agonist Models, Specifications and Application

Table 56. Gilead Sciences Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Gilead Sciences Company Profile and Main Business

Table 58. Gilead Sciences Recent Developments

Table 59. CRISPR Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 60. CRISPR Therapeutics Prostacyclin Receptor Agonist Models, Specifications and Application

Table 61. CRISPR Therapeutics Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. CRISPR Therapeutics Company Profile and Main Business

Table 63. CRISPR Therapeutics Recent Developments

Table 64. Chiesi Farmaceutici Company Information, Head Office, Market Area and Industry Position

Table 65. Chiesi Farmaceutici Prostacyclin Receptor Agonist Models, Specifications and Application

Table 66. Chiesi Farmaceutici Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Chiesi Farmaceutici Company Profile and Main Business

Table 68. Chiesi Farmaceutici Recent Developments

Table 69. Bayer AG Company Information, Head Office, Market Area and Industry Position

Table 70. Bayer AG Prostacyclin Receptor Agonist Models, Specifications and Application

Table 71. Bayer AG Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Bayer AG Company Profile and Main Business

Table 73. Bayer AG Recent Developments

Table 74. Arena Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 75. Arena Pharmaceuticals Prostacyclin Receptor Agonist Models, Specifications and Application

Table 76. Arena Pharmaceuticals Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Arena Pharmaceuticals Company Profile and Main Business

Table 78. Arena Pharmaceuticals Recent Developments

Table 79. Actelion Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 80. Actelion Pharmaceuticals Prostacyclin Receptor Agonist Models, Specifications and Application

Table 81. Actelion Pharmaceuticals Prostacyclin Receptor Agonist Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Actelion Pharmaceuticals Company Profile and Main Business

Table 83. Actelion Pharmaceuticals Recent Developments

List of Figure

Figure 1. Prostacyclin Receptor Agonist Picture

Figure 2. By Revenue, Global Prostacyclin Receptor Agonist Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Prostacyclin Receptor Agonist Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Prostacyclin Receptor Agonist Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Prostacyclin Receptor Agonist Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Prostacyclin Receptor Agonist Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Prostacyclin Receptor Agonist Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Prostacyclin Receptor Agonist Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Prostacyclin Receptor Agonist Share of Global Market, 2018-2029

Figure 10. Global Prostacyclin Receptor Agonist Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Prostacyclin Receptor Agonist Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Prostacyclin Receptor Agonist Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Prostacyclin Receptor Agonist Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Prostacyclin Receptor Agonist Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Prostacyclin Receptor Agonist Domestic VS Export, 2022

Figure 16. Global Prostacyclin Receptor Agonist Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Prostacyclin Receptor Agonist Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Prostacyclin Receptor Agonist Production Market Share & Forecast by Region, 2018-2029

Figure 19. Prostacyclin Receptor Agonist Industry Chain

Figure 20. Prostacyclin Receptor Agonist Procurement Model

Figure 21. Prostacyclin Receptor Agonist Sales Model

Figure 22. Prostacyclin Receptor Agonist Sales Channels, Direct Sales and Distribution

Figure 23. Epoprostenol Sodium

Figure 24. Treprostinil

Figure 25. Beraprost

Figure 26. By Type, Global Prostacyclin Receptor Agonist Revenue, 2018-2029, US$ Million

Figure 27. By Type, Global Prostacyclin Receptor Agonist Revenue Market Share, 2018-2029

Figure 28. By Type, Global Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 29. By Type, Global Prostacyclin Receptor Agonist Sales Volume Market Share, 2018-2029

Figure 30. By Type, Global Prostacyclin Receptor Agonist Price, 2018-2029, (US$/Unit)

Figure 31. Hospital

Figure 32. Pharmaceutical Company

Figure 33. Laboratory

Figure 34. Clinic

Figure 35. Others

Figure 36. By Application, Global Prostacyclin Receptor Agonist Revenue, 2018-2029, US$ Million

Figure 37. By Application, Global Prostacyclin Receptor Agonist Revenue Market Share, 2018-2029

Figure 38. By Application, Global Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 39. By Application, Global Prostacyclin Receptor Agonist Sales Volume Market Share, 2018-2029

Figure 40. By Application, Global Prostacyclin Receptor Agonist Price, 2018-2029, (US$/Unit)

Figure 41. By Region, Global Prostacyclin Receptor Agonist Revenue Market Share, 2018-2029

Figure 42. By Region, Global Prostacyclin Receptor Agonist Sales Volume Market Share, 2018-2029

Figure 43. North America Prostacyclin Receptor Agonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country, North America Prostacyclin Receptor Agonist Revenue Market Share, 2022

Figure 45. Europe Prostacyclin Receptor Agonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, Europe Prostacyclin Receptor Agonist Revenue Market Share, 2022

Figure 47. Asia Pacific Prostacyclin Receptor Agonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. By Country/Region, Asia Pacific Prostacyclin Receptor Agonist Revenue Market Share, 2022

Figure 49. South America Prostacyclin Receptor Agonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 50. By Country, South America Prostacyclin Receptor Agonist Revenue Market Share, 2022

Figure 51. Middle East & Africa Prostacyclin Receptor Agonist Revenue & Forecasts, 2018-2029, US$ Million

Figure 52. U.S. Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 53. By Company, U.S. Prostacyclin Receptor Agonist Market Share, 2022

Figure 54. By Type, U.S. Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, U.S. Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 56. Europe Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 57. By Company, Europe Prostacyclin Receptor Agonist Market Share, 2022

Figure 58. By Type, Europe Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, Europe Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 60. China Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 61. By Company, China Prostacyclin Receptor Agonist Market Share, 2022

Figure 62. By Type, China Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, China Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 64. Japan Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 65. By Company, Japan Prostacyclin Receptor Agonist Market Share, 2022

Figure 66. By Type, Japan Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, Japan Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 68. South Korea Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 69. By Company, South Korea Prostacyclin Receptor Agonist Market Share, 2022

Figure 70. By Type, South Korea Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, South Korea Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 72. Southeast Asia Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 73. By Company, Southeast Asia Prostacyclin Receptor Agonist Market Share, 2022

Figure 74. By Type, Southeast Asia Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, Southeast Asia Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 76. India Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 77. By Company, India Prostacyclin Receptor Agonist Market Share, 2022

Figure 78. By Type, India Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, India Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 80. Middle East & Asia Prostacyclin Receptor Agonist Sales Volume, 2018-2029, (K Units)

Figure 81. By Company, Middle East & Asia Prostacyclin Receptor Agonist Market Share, 2022

Figure 82. By Type, Middle East & Asia Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 83. By Application, Middle East & Asia Prostacyclin Receptor Agonist Sales Volume Market Share, 2022 VS 2029

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches